• 1
    Cowan DH, Graham RC, Baunach D. The platelet defect in leukemia. Platelet ultrastructure, adenine nucleotide metabolism, and the release reaction. J Clin Invest 1975; 56: 188200.
  • 2
    Pamphilon DH, Aparicio SR, Roberts BE, Menys VC, Tate G, Davies JA. The myelodysplastic syndromes. A study of hemostatic function and platelet ultrastructure. Scand J Haematol 1984; 33: 48691.
  • 3
    Stuart JJ, Lewis JC. Platelet aggregation and electron microscopic studies of platelets in preleukemia. Arch Pathol Lab Med 1982; 106: 45861.
  • 4
    Schattner E, Bussel J. Mortality in immune thrombocytopenic purpura: report of seven cases and consideration of prognostic indicators. Am J Hematol 1994; 46: 1206.
  • 5
    Clancy R, Jenkins E, Firkin B. Qualitative platelet abnormalities in idiopathic thrombocytopenic purpura. N Engl J Med 1972; 286: 6226.
  • 6
    Zahavi J, Marder VJ. Acquired ‘storage pool disease’ of platelets associated with circulating antiplatelet antibodies. Am J Med 1974; 56: 88390.
  • 7
    Weiss HJ, Rosove MH, Lages BA, Kaplan KL. Acquired storage pool deficiency with increased platelet-associated IgG. Am J Med 1980; 69: 7117.
  • 8
    Stuart MJ, Kelton JG, Allen JB. Abnormal platelet function and arachidonate metabolism in chronic idiopathic thrombocytopenic purpura. Blood 1981; 58: 3269.
  • 9
    Balduini CL, Bertolino G, Noris P, Piovella F, Sinigaglia F, Bellotti V, et al. Defect of platelet aggregation and adhesion induced by autoantibodies against platelet glycoprotein IIIa. Thromb Haemost 1992; 68: 20813.
  • 10
    Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev 2002; 16: 3445.
  • 11
    Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362: 60013.
  • 12
    Stanworth SJ, Estcourt L, Powter G, Kahan BC, Dyer C, Bakrania L, Llewelyn C, Choo L, Bielby L, Norfolk D, Wood EM, Murphy MF. The Effect of a No-Prophylactic Versus Prophylactic Platelet Transfusion Strategy On Bleeding in Patients with Hematological Malignancies and Severe Thrombocytopenia (TOPPS trial). A Randomized Controlled, Non-Inferiority Trial. Blood. (ASH Annual Meeting Abstracts), 2012;120: 1.
  • 13
    Psaila B, Bussel JB, Frelinger AL, Babula B, Linden MD, Li Y, Barnard MR, Tate C, Feldman EJ, Michelson AD. Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia. J Thromb Haemost 2011; 9: 230210.
  • 14
    Buyukasik Y, Ozatli D, Sayinalp N, Haznedaroglu IC, Kirazli S, Ozcebe OI, Dundar SV. Lumiaggregometry can be used for estimation of platelet functions in patients with thrombocytopenia. Blood (ASH Annual Meeting Abstracts) 1999; 94: 3503.
  • 15
    Buyukasik Y, Goker H, Buyukasik NS, Sayinalp N, Haznedaroglu IC, Ozcebe OI. Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients. Blood Coagul Fibrinolysis 2008; 19: 6337.